PhaRmacogEnomiC medIcines optimiSatIon for peOple with caNcer – a multicentre teletrial enabled Interrupted Time Series trial (PRECISION-ITS): Pharmacogenomics Education & Implementation Program for Pharmacists

Not Applicable

• Conditions: Cancer and other malignant neoplasms; Cancer - Any cancer; Public Health - Health service research

• Registration Number: ACTRN12624000091505
• Lead Sponsor: Peter MacCallum Cancer Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2024-02-01
• Last Update Posted: 12 February 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

National KAP Survey - Healthcare professionals (adult oncology)
1. Cancer healthcare professional (medical oncologist, haematologist, pharmacist, or nurse)
2. Cares for people with cancer at an Australian hospital, or managers or clinical supervisors of healthcare professionals who care for people with cancer at an Australian hospital
3. English language reading capability to complete surveys

National KAP Survey - Consumers (adult oncology)
1. Adults, aged > 18 years
2. Have had treatment for cancer, or cared for a person who has had treatment for cancer in the Australian healthcare system
3. English language reading capability to complete surveys

National KAP Survey - Adolescents & Young Adults (AYA) (paediatric oncology)
1. AYA aged > 15 years who have a diagnosis of cancer or immunosuppression
2. Have had treatment for cancer, or cared for a person who has had treatment for cancer in the Australian healthcare system
3. English language reading capability to complete surveys

National KAP Survey - Carers (paediatric oncology)
1. Caregiver of a child who has received a diagnosis of cancer or immunosuppression (current or recent)
2. Caregiver of a child who has had treatment for cancer in the Australian healthcare system
3. English language reading capability to complete surveys

National KAP Survey - Healthcare professionals (paediatric oncology)
1. Cancer healthcare professional (medical oncologist, haematologist, pharmacist, or nurse)
2. Cares for people with cancer at an Australian hospital, or managers or clinical supervisors of healthcare professionals who care for people with cancer at an Australian hospital
3. English language reading capability to complete surveys

Pharmacogenomics Education/Implementation Program:
1. Pharmacists at PRECISION-ITS primary and satellite sites.

Exclusion Criteria

National KAP Survey - Adolescents & Young Adults (AYA) (paediatric oncology)
1. AYA must not be participating in the MARVEL-PIC study (NCT05667766).

National KAP Survey - Carers (paediatric oncology)
1. Child of caregiver must not be participating in the MARVEL-PIC study (NCT05667766).

Study & Design

• Study Type: Interventional
• Study Design: Not specified